Anthropic has announced a new initiative under its AI for Science program, focusing on rare genetic diseases. The program offers grants of up to $50,000 in Claude credits to researchers and biotechs. The goal is to use AI to model diseases, detect patterns, and accelerate drug development. This initiative could transform how rare diseases are understood and treated, addressing the challenges of limited data and slow therapeutic development.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
TechCrunch AI · April 30, 2026 · Related
Anthropic · May 14, 2026 · Same story
Crunchbase News · May 28, 2026 · Related
The Rundown AI · May 29, 2026 · Related
Sifted · June 1, 2026 · Related
TechCrunch AI · June 30, 2026 · Related
MIT Technology Review AI · June 30, 2026 · Same story
The Verge AI · July 3, 2026 · Same story
Matt Wolfe · July 31, 2026 · Related
The Rundown AI · August 20, 2026 · Related
Anthropic · August 25, 2026 · Same story
The Verge AI · September 23, 2026 · Related
The AI Daily Brief · October 29, 2026 · Related
Anthropic invests $10M in Canadian AI research
4 developments
© Cole MedinAnthropic’s latest research exposes a quiet but dangerous flaw in agentic workflows: experts follow AI recommendations 86% of the time, often adopting the agent's reasoning as their own. This isn't just about accuracy; it's about cognitive capture, where human oversight dissolves into passive compliance. The study shows that even when users believe they are steering, the agent’s framing dictates the outcome. Practitioners must now actively counter this bias by forcing agents to justify deviations or prototype alternatives before committing to a path. This shift demands a new discipline in how we interact with coding assistants. We can no longer assume our intent drives the result; the model's suggestion often becomes the default truth. The real work is ensuring we remain the architects, not just the approvers.
© WIRED AICisco Talos has uncovered a new infostealer strain that actively uses commercial LLMs to profile victims and prioritize high-value targets. Dubbed Volta-Autodoxer, the malware collects credentials and browsing data, then feeds this into models like Claude Opus 4.6 via OpenRouter to generate structured intelligence dossiers. This marks a shift from passive data theft to active, AI-driven triage, allowing attackers to bypass guardrails with fallback models like Kimi K2 or Gemini. The capability foreshadows a future where lower-sophistication criminals can execute sophisticated, targeted attacks at scale.
© Matt WolfeOpenAI researchers published findings disproving the Exponential Time Hypothesis, a major result in computational complexity theory.